Eswatini vs Republic of Moldova: The number of people with susceptibility test result for rifampicin
Eswatini
953
in 2021
Republic of Moldova
991
in 2021
Eswatini rank
68th
Republic of Moldova rank
67th
The number of people with susceptibility test result for rifampicin over time
- Eswatini
- Republic of Moldova
How they compare
Republic of Moldova currently reports 991 against 953 in Eswatini, a difference of 38.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Eswatini ahead.
Eswatini ranks 68th and Republic of Moldova ranks 67th of 155 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,737 | 1,394 | 343 | Eswatini |
| 2020s | 1,028 | 915.5 | 113 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Eswatini or Republic of Moldova?
- Republic of Moldova, at 991 against 953 in Eswatini as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Eswatini and Republic of Moldova?
- 38, with Republic of Moldova ahead.
- How many years of comparable data are there for Eswatini and Republic of Moldova?
- 5 years are reported by both, from 2017 to 2021.
- How do Eswatini and Republic of Moldova rank globally for the number of people with susceptibility test result for rifampicin?
- Eswatini ranks 68th and Republic of Moldova ranks 67th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.